Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy

By Filippi Andrea Riccardo  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1183-1187

Informa Healthcare

Access to resources Recommend Favorite

Clinical features of patients with nonHodgkin's lymphoma metastasizing to the pituitary glands

By        

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1643-1648

Spandidos Publications

Access to resources Recommend Favorite

Ki-67 proliferative marker in lymph node aspirates of patients with non-Hodgkin's lymphoma

By Mihaljevic B.   Nedeljkov-Janćić R.   Ćemerikić-Martinović V.   Babić D.   Čolović M.  

Medical Oncology, Vol. 23, Iss. 1, 2006-03 ,pp. : 83-89

Humana Press, Inc

Access to resources Recommend Favorite

High-grade Non-Hodgkin's Lymphoma Treated in Northern Norway: Treatment, Outcome, and Prognostic Factors

By Bremnes Roy Martin   Bremnes Yngve   Dønnem Tom  

Acta Oncologica, Vol. 38, Iss. 1, 1999-02 ,pp. : 117-124

Informa Healthcare

Access to resources Recommend Favorite

CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma

By Kayal Smita   Mathur Sandeep   Karak Asis K.   Kumar Lalit   Sharma Atul   Bakhshi Sameer   Raina Vinod  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1031-1037

Informa Healthcare

Access to resources Recommend Favorite